Black women treated with neoadjuvant endocrine therapy for breast cancer were more likely to benefit than white women if treated at an earlier disease stage but less likely to benefit than white women if treated at a later disease stage, according to results presented at the 15th AACR Conference on the Science…
in Health
Neoadjuvant endocrine therapy may elicit differential responses in Black and white women with breast cancer
